Autoinjectors Market Report Revenue Growth and Industry Outlook
According to Rohan Patil, who specializes in medical devices, drug delivery systems, and healthcare market intelligence, with 5+ years of experience in market research and industry analysis. His research indicates that the autoinjectors market is set to grow from USD 4.42 billion in 2026 to USD 12.05 billion by 2035, driven by rising adoption of self-administration technologies and increasing demand for biologics. The analysis highlights disposable autoinjectors, subcutaneous administration, rheumatoid arthritis applications, and homecare settings as key revenue-generating segments. North America currently leads the market, while Asia Pacific is expected to record the fastest growth. The competitive landscape remains shaped by major participants including Eli Lilly and Company, Amgen, Ypsomed, SHL Medical, and AbbVie, which continue to advance innovation and expand market presence.
Last Updated : 04 August 2026
Category: Therapeutic Area
Insight Code: 6865
Format: PDF / PPT / Excel